Local Control and Long-Term Disease-Free Survival for Stage D1 (T2-T4N1-N2M0) Prostate Cancer After Radical Prostatectomy in the PSA Era

Urology

Volumn 70, Issue 4, 2007, Pages 723-727

  Gjertson, Carl K ^a   Asher, Kevin P ^a   Sclar, Joshua D ^a   Goluboff, Erik T ^a   Olsson, Carl A ^a   Benson, Mitchell C ^a   McKiernan, James M ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; KAPLAN MEIER METHOD; LIFE EXPECTANCY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME;

AGED; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; DISEASE-FREE SURVIVAL; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 35649026770     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.05.014     Document Type: Article

References (16)

1. Ung J.O., Richie J.P., Chen M.H., et al. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology 60 (2002) 458-463
2. Jemal A., Murray T., Samuels A., et al. Cancer statistics, 2003. CA Cancer J Clin 53 (2003) 5-26
3. Buskirk S.J., Pisansky T.M., Atkinson E.J., et al. Lymph-node positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapy. Mayo Clin Proc 76 (2001) 702-706
4. Haese A., Epstein J.I., Huland H., et al. Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma. Cancer 95 (2002) 1016-1021
5. Seay T.M., Blute M.C., and Zinke H. Radical prostatectomy and early adjuvant hormonal therapy for pTxN+ adenocarcinoma of the prostate. Urology 50 (1997) 833-837
6. Walsh P.C., and Donker P.J. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 128 (1982) 492-497
7. Arias E. United States life tables, 2000. Natl Vital Stat Rep 51 (2002)
8. Palapattu G.S., Allaf M.E., Trock B.J., et al. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term follow-up. J Urol 172 (2004) 1860-1864
9. Zinke H., Utz D.C., Myers R.P., et al. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma of the prostate with regional lymph node involvement. Urology 19 (1982) 238-247
10. Cheng L., Zinke H., Blute M.L., et al. Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91 (2001) 66-73
11. Grimm M.O., Kamphausen S., Hugenschmidt H., et al. Clinical outcome of patients with node positive prostate cancer after radical prostatectomy versus androgen deprivation. Eur Urol 41 (2002) 628-634
12. Ghavamian R., Bergstralh E.J., Blute M.L., et al. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison. J Urol 161 (1999) 1223-1228
13. Bader P., Burkhard F.C., Markwalder R., et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy: is there a chance of cure?. J Urol 169 (2003) 849-854
14. Messing E.M., Manola J., Sarosdy M., et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341 (1999) 1781-1788
15. Frazier II H.A., Robertson J.E., and Paulson D.F. Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival?. World J Urol 12 (1994) 308-312
16. Zwergel U., Lehmann J., Wullich B., et al. Lymph node positive prostate cancer: long-term survival data after radical prostatectomy. J Urol 171 (2004) 1128-1131